Pharmaceutical products for in vivo use in respect to heamatopoietic malignancies, solid tumors, angiogenic disorders, infections and genetic diseases

Cells for medical or clinical use, namely for use in respect to heamatopietic malignancies, namely HIV replication and solid tumors

Pharmaceutical preparations for use in gene and cell therapy and molecular medicine